Recombinant multi-species TMEM50A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TMEM50A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is located in the RH gene locus, between the RHD and RHCE genes. The function of its protein product is unknown; however, its sequence has potential transmembrane domains suggesting that it may be an integral membrane protein. Its position between the RH genes suggests that polymorphisms in this gene may be tightly linked to RH haplotypes and may contribute to selective pressure for or against certain RH haplotypes. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 3200001F09Rik,CAM,IFNRC,RGD1305638,SMP1,Small membrane protein 1,Smp1,TMEM50A,Tmem50a,Transmembrane protein 50A

Target products collectionGo to TMEM50A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP2107-Ag-1/ GM-Tg-hg-IP2107-Ag-2 Human TMEM50A protein Human
GM-Tg-rg-IP2107-Ag-1/ GM-Tg-rg-IP2107-Ag-2 Rat TMEM50A protein Rat
GM-Tg-mg-IP2107-Ag-1/ GM-Tg-mg-IP2107-Ag-2 Mouse TMEM50A protein Mouse
GM-Tg-cynog-IP2107-Ag-1/ GM-Tg-cynog-IP2107-Ag-2 Cynomolgus/Rhesus macaque TMEM50A protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP2107-Ag-1/ GM-Tg-felg-IP2107-Ag-2 Feline TMEM50A protein Feline
GM-Tg-cang-IP2107-Ag-1/ GM-Tg-cang-IP2107-Ag-2 Canine TMEM50A protein Canine
GM-Tg-bovg-IP2107-Ag-1/ GM-Tg-bovg-IP2107-Ag-2 Bovine TMEM50A protein Bovine
GM-Tg-equg-IP2107-Ag-1/ GM-Tg-equg-IP2107-Ag-2 Equine TMEM50A protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP2107-Ag-1/ GM-Tg-hg-IP2107-Ag-2; GM-Tg-rg-IP2107-Ag-1/ GM-Tg-rg-IP2107-Ag-2;
GM-Tg-mg-IP2107-Ag-1/ GM-Tg-mg-IP2107-Ag-2; GM-Tg-cynog-IP2107-Ag-1/ GM-Tg-cynog-IP2107-Ag-2;
GM-Tg-felg-IP2107-Ag-1/ GM-Tg-felg-IP2107-Ag-2; GM-Tg-cang-IP2107-Ag-1/ GM-Tg-cang-IP2107-Ag-2;
GM-Tg-bovg-IP2107-Ag-1/ GM-Tg-bovg-IP2107-Ag-2; GM-Tg-equg-IP2107-Ag-1/ GM-Tg-equg-IP2107-Ag-2
Products Name TMEM50A protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name TMEM50A
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TMEM50A protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.